Negative Pressure Wound Therapy (NPWT) Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Negative Pressure Wound Therapy (NPWT) Market is segmented By Device Type (Conventional NPWT Systems, Single-use NPWT Devices), By Dressings (Polysaccharides, Hydrocolloids Dressings, Gauze Dressings, Drapes, Others), By Wound Type (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Burns, Surgical & Traumatic Wounds, Other Wounds), By End-User (Hospital & Clinics, Homecare, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030

Market Overview

Global Negative Pressure Wound Therapy (NPWT) Market reached US$ YY billion in 2022 and is expected to reach US$ YY  million by 2031 growing at a CAGR of YY% during the forecast period 2024-2031.

Negative Pressure Wound Therapy (NPWT) is a therapeutic method for healing second and third-degree burns, and chronic or acute wounds that use a suction pump, tubing, and dressing to remove excess exudate.

Negative Pressure Wound Therapy (NPWT) promotes angiogenesis by increasing blood flow to the wound site. Enhanced perfusion delivers oxygen and nutrients to the wound bed, supporting cellular proliferation, tissue regeneration, and collagen synthesis, which are essential for wound healing.

Market Scope

For more details on this report – Request for Sample 

Market Dynamics

Growing prevalence of chronic wounds

The increasing prevalence of chronic wounds acts as a significant driver for market growth. Chronic wounds include various types, such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, and non-healing surgical wounds.

For instance, the annual incidence of diabetic foot ulcers worldwide is between 9.1 to 26.1 million. Around 15 to 25% of patients with diabetes mellitus develop a diabetic foot ulcer during their lifetime. Also, the number of adult diabetic patients in China is a total of 116.4 million among which the incidence of diabetic foot (DF) is as high as 30%.

Additionally, according to the Canadian Maple report, there are between 77,600 and 116,400 diabetic foot ulcers in Canada and up to 25% of the nearly 4 million Canadians living with diabetes will develop a diabetic foot ulcer (DFU) in their lifetime, with a 20% associated risk of limb loss.

Furthermore, significant growth drivers such as the rising technological advancements for NPWT devices, and the rising traumatic accidents are expected to drive the market in the forecast period.

Risk of complications

Negative Pressure Wound Therapy (NPWT) can help reduce the risk of infection by removing exudate and promoting wound healing. However, improper application or maintenance of NPWT can lead to wound contamination or infection. Also, prolonged negative pressure applied to the wound bed can cause skin irritation, blistering, or trauma around the wound site.

Market Segment Analysis

The global negative pressure wound therapy (NPWT) market is segmented based on device type, dressings, wound type, end users and region.

The polysaccharides segment accounted for approximately 56.4% of the market share 

The polysaccharides segment is expected to hold the largest market share over the period forecast. Polysaccharide dressings are made from natural or synthetic materials derived from sugars. They are designed to provide a moist wound healing environment, facilitate autolytic debridement, and promote tissue regeneration

Some polysaccharide dressings also possess antimicrobial properties which helps to reduce the risk of wound infection and support the healing process. It can also conform to the wound contours, providing comfort to the patient and minimizing trauma during dressing changes.

For instance, in August 2023, Medela expanded its negative pressure wound therapy (NPWT) portfolio by introducing the new Invia Integrated Dressing indicated for all types of wounds. It has a three-layer fluid handling pad that has a skin-friendly silicone adhesive border.

Market Geographical Analysis

North America is expected to hold a significant position in the global portable medical devices market share

The global negative pressure wound therapy (NPWT) market is segmented into North America, Europe, Asia Pacific, South America, Middle East and Africa. 

North America has maintained a significant market proportion due to factors such as the increasing prevalence of diabetes, technological advancements, and increasing healthcare expenditure, this trend is anticipated to continue throughout the forecast period.

For instance, in April 2023, 3M Veraflo Therapy dressings received the FDA clearance for hydromechanical removal of non-viable tissue. It is the only negative pressure wound therapy (NPWT) dressing that hydromechanically removes non-viable tissue.

Additionally, according to the Centers for Disease Control and Prevention report 2021, diabetes prevalence significantly increased among US adults 18 or older. Around,38.4 million people have diabetes which is 11.6% of the US population. Hence, the rising prevalence of diabetes can lead to diabetic foot ulcers.

COVID-19 Impact Analysis On Negative Pressure Wound Therapy (NPWT) Market

The COVID-19 pandemic has had a significant impact on the global negative pressure wound therapy (NPWT) market. The market faced challenges related to supply chain disruptions, manufacturing delays, and shortages of raw materials and components due to lockdowns, travel restrictions, and disruptions in global trade. However, the patients with COVID-19-related complications, prolonged hospitalizations, and limited mobility were at higher risk of developing wounds, which led to the use of NPWT and other advanced wound therapies. Therefore, owing to the above factors, the negative pressure wound therapy (NPWT) market was moderately affected over the forecast period.

Market Competitive Landscape

The major global players in the market include 3M Company, Advin Health Care, Medela AG, Gilero, Smith & Nephew Plc, Cardinal Health Inc., Convatec Inc., Talley Group Ltd, Mölnlycke Health Care AB, and DeRoyal among others.

Key Developments

• In May 2023, Smith+Nephew received an Innovative Technology contract from Vizient, Inc. for its PICO Single Use Negative Pressure Wound Therapy Systems. The PICO sNPWT System provides a portable, easy to use, canister-free design and is equipped with the comfort and mobility of Smith+Nephew soft port technology.

Why Purchase the Report?

• To visualize the global negative pressure wound therapy (NPWT) market segmentation based on device type, dressings, wound type and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of global negative pressure wound therapy (NPWT) market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global negative pressure wound therapy (NPWT) market report would provide approximately 61 tables, 58 figures, and 185 Pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Trending Reports:

Sleep Apnea Devices Market

Pain Management Devices Market

Kidney Stone Management Devices Market